Remove Cardiology Remove Doctors Remove FDA Approval Remove Regulation
article thumbnail

Former FDAer Dr. Ellis F. Unger Joins Hyman, Phelps & McNamara, P.C. as Principal Drug Regulatory Expert

FDA Law Blog

Unger’s Office oversaw the approval and regulation of scores of new drugs for cardiovascular, renal, neurological, and psychiatric disorders. He completed his cardiology training at The Johns Hopkins Hospital in 1987. We are thrilled and humbled that someone with Dr. Unger’s background has chosen to work with us.

Drugs 40
article thumbnail

Amarin Reports Third Quarter 2020 Financial Results and Provides Business Update

The Pharma Data

In the process of hiring select people with extensive commercial experience in Europe and preparing for post-approval market access negotiations. Amarin is optimistic that the worst period of impact from COVID-19 on the levels of patients seeking ordinary course doctor visits and lab tests may be behind it.

Sales 40